Last reviewed · How we verify
Epithelioid sarcoma
Approved treatments
- Tazverik · Epizyme Inc
Tazverik works by blocking the action of the EED protein, which is involved in the regulation of gene expression. - Tazverik · Epizyme Inc
Tazverik works by blocking the action of an enzyme called EED, which is involved in the production of proteins that promote cancer growth. - Tazverik · Edwin Posadas, MD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Epithelioid sarcoma patent landscape — cliff calendar, originator estates, attackable patents
- Epithelioid sarcoma treatment landscape brief
- Epithelioid sarcoma treatment updates RSS
Frequently asked questions about Epithelioid sarcoma
What drugs treat Epithelioid sarcoma?
Tracked treatments include Tazverik.
What is the treatment for Epithelioid sarcoma?
Standard treatment for Epithelioid sarcoma includes Tazverik. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Epithelioid sarcoma patent cliff · Epithelioid sarcoma CI report
- Treatment: Tazverik · Epizyme Inc
- Treatment: Tazverik · Epizyme Inc
- Treatment: Tazverik · Edwin Posadas, MD
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing